- Home
- BCRX vs CERT Comparison
BCRX vs CERT Comparison
Compare BCRX & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- CERT
- Stock Information
- Founded
- BCRX 1986
- CERT 2008
- Country
- BCRX United States
- CERT United States
- Employees
- BCRX N/A
- CERT N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- BCRX Health Care
- CERT Technology
- Exchange
- BCRX Nasdaq
- CERT Nasdaq
- Market Cap
- BCRX 1.9B
- CERT 1.5B
- IPO Year
- BCRX 1994
- CERT 2020
- Fundamental
- Price
- BCRX $8.45
- CERT $11.02
- Analyst Decision
- BCRX Strong Buy
- CERT Buy
- Analyst Count
- BCRX 10
- CERT 7
- Target Price
- BCRX $16.70
- CERT $15.00
- AVG Volume (30 Days)
- BCRX 3.5M
- CERT 1.5M
- Earning Date
- BCRX 08-04-2025
- CERT 08-06-2025
- Dividend Yield
- BCRX N/A
- CERT N/A
- EPS Growth
- BCRX N/A
- CERT N/A
- EPS
- BCRX N/A
- CERT 0.05
- Revenue
- BCRX $557,506,000.00
- CERT $405,755,000.00
- Revenue This Year
- BCRX $37.96
- CERT $11.52
- Revenue Next Year
- BCRX $8.82
- CERT $8.74
- P/E Ratio
- BCRX N/A
- CERT $221.31
- Revenue Growth
- BCRX 45.85
- CERT 11.61
- 52 Week Low
- BCRX $6.02
- CERT $8.64
- 52 Week High
- BCRX $11.31
- CERT $15.69
- Technical
- Relative Strength Index (RSI)
- BCRX 46.82
- CERT 51.88
- Support Level
- BCRX $8.08
- CERT $10.38
- Resistance Level
- BCRX $8.64
- CERT $11.26
- Average True Range (ATR)
- BCRX 0.33
- CERT 0.49
- MACD
- BCRX 0.06
- CERT 0.12
- Stochastic Oscillator
- BCRX 43.90
- CERT 66.08
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.